Top Banner
FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS Thursday, 31 st January 2019 10:00 – 19:00 Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich Handelskammer Schweiz – Israel, Postfach 1564, 8027 Zürich TEL 044 362 16 30 | [email protected] | www.swissisrael.ch Rodin Aeschbach Founder & CEO of Pharmotech SA Switzerland Adv. Inbal Faibish Wassmer Partner, ROSAK - Rosenberg Abramovich Keren-Polak & Co., Advocates Anand Shahi CEO of Bar Capital, Israel Dr. Hadar Less CEO of Cannika & co-founder Yarok Medtech Israel Dr. Daniela Eigenmann Pharmacist, Apotheke Langnau i.E., Swiss pharmacy selling medical cannabis Prof. Simon Benita, PhD Head laboratory of Nano Delivery Systems at Cannabinoids Research Multidisciplinary Center, Hebrew University Israel Saul Kaye CEO, iCAN Israel, advisor to medical cannabis commitee of the Knesset Mr. Jacob Keidar Ambassador of the State of Israel to Switzerland Dr. Inbar Maymon Pomeranchik Scientific Due Diligence Expert, specializing in global medical cannabis, Israel Dr. Jonathan Grunfel Neurologist, palliative care, Asaf Harofeh Medical Center, Israel Irit Avisar President, co-founder Israel Medical Cananabis Nursing Association Bea Goldman CEO Medcanned, intensive care specialist ALS nurse, Switzerland Margrit Kessler Member of Swiss Parlament 2011 - 2015, initiated motion for medical cannabis Daniel Gutenberg General Partner at VI Partners AG Switzerland, business angel and investor Prof. Eli Alon M.D. Professor of Anesthesiology and pain medicine University of Zurich. Director Interdisciplinary pain control unit Dr. Miri Halperin Wernli CEO Creso Pharma Switzerland Daniel Furman Founder & Managing Director of ARBA Finance Company, Israel Laura Herschlag COO of Cannika & co-founder of Yarok Medtech Ltd., Israel Dr. Catherine Ritter Federal office of public health, Berne Our speakers Handelskammer Schweiz-Israel Chambre de Commerce Suisse-Israël Chamber of Commerce Switzerland-Israel Our sponsors SWISS FRIENDS OF
2

FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL …€¦ · Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS Thursday, 31st

Jun 22, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL …€¦ · Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS Thursday, 31st

FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS

Thursday, 31st January 201910:00 – 19:00

Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich

Handelskammer Schweiz – Israel, Postfach 1564, 8027 ZürichTEL 044 362 16 30 | [email protected] | www.swissisrael.ch

Rodin Aeschbach Founder & CEO of Pharmotech SA Switzerland

Adv. Inbal Faibish Wassmer Partner, ROSAK - Rosenberg Abramovich Keren-Polak & Co., Advocates

Anand Shahi CEO of Bar Capital, Israel

Dr. Hadar Less CEO of Cannika & co-founder Yarok Medtech Israel

Dr. Daniela Eigenmann Pharmacist, Apotheke Langnau i.E., Swiss pharmacy selling medical cannabis

Prof. Simon Benita, PhD Head laboratory of Nano Delivery Systems at Cannabinoids Research Multidisciplinary Center, Hebrew University Israel

Saul Kaye CEO, iCAN Israel, advisor to medical cannabis commitee of the Knesset

Mr. Jacob Keidar Ambassador of the State of Israel to Switzerland

Dr. Inbar Maymon Pomeranchik Scientific Due Diligence Expert, specializing in global medical cannabis, Israel

Dr. Jonathan Grunfel Neurologist, palliative care, Asaf Harofeh Medical Center, Israel

Irit Avisar President, co-founder Israel Medical Cananabis Nursing Association

Bea Goldman CEO Medcanned, intensive care specialist ALS nurse, Switzerland

Margrit Kessler Member of Swiss Parlament 2011 - 2015, initiated motion for medical cannabis

Daniel Gutenberg General Partner at VI Partners AG Switzerland, business angel and investor

Prof. Eli Alon M.D. Professor of Anesthesiology and pain medicine University of Zurich. Director Interdisciplinary pain control unit

Dr. Miri Halperin Wernli CEO Creso Pharma Switzerland

Daniel Furman Founder & Managing Director of ARBA Finance Company, Israel

Laura Herschlag COO of Cannika & co-founder of Yarok Medtech Ltd., Israel

Dr. Catherine Ritter Federal office of public health, Berne

Our speakers

Handelskammer Schweiz-IsraelChambre de Commerce Suisse-IsraëlChamber of Commerce Switzerland-Israel

Our sponsorsSWISS FRIENDS OF

Page 2: FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL …€¦ · Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS Thursday, 31st

Welcome to the first Swiss-Israel Medical Cannabis Invest-ment Summit focused on investing in Israel’s medical canna-bis innovation.

Supported by Innosuisse and supervised by federal office of public health BAG.

Medical cannabis is one of the fastest growing emerging industries of the 21st century. Switzerland prepares for the legalization of medical cannabis. This timely event introduc-es Israel’s world leading medical cannabis ecosystem. It offers opportunities for collaboration to doctors, people from MedCann manufacturing and pharmaceutical indus-tries, Swiss investors, business people, and scientific com-munity.

Join us to learn about:

• How scientists and researchers from world renown institutions are creating the future of cannabinoid medicine

• Clinical trials on cannabinoid based treatments in progress in Israel’s leading hospitals

• Medical experience of doctors, carers and patients with cannabinoid medicine in Israel and Switzerland

• Attractive investment opportunities in Israel’s medical cannabis industry

• Public and private endeavors to foster technology innovation in agricultural, processing, production, and medical technologies

AGENDA

Registration: e-mail to [email protected] to Post-Finance 80-32379-6IBAN CH47 0900 0000 8003 2379 6No refund

Handelskammer Schweiz-IsraelChambre de Commerce Suisse-IsraëlChamber of Commerce Switzerland-Israel

Entry fee including luncheon:CHF 120 for member of the Chamber of Commerce Switzerland IsraelCHF 160 for non-member (early birds until 31st December 2018: CHF 120)

Registration & coffee 09:00

Legal and Regulatory Environment 10:00

Opportunities in New Technology and Pharmaceuticals, Panel 10:40

Lunch break 12:20

Israel’s government approach vis-à-vis MedCann; 13:05

Investing in Israeli Medical Cannabis Companies, Panel 1 3 : 1 5

The Medical Experience 1 4 : 1 5

Coffee break 15:35

The Medical Experience, Panel 15:50

Pitch session with Israeli MedCann startups 16:20

Reception and Networking 17:30

For detailed program and speakers’ list: www.canninvest.ch